Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802449 · ClinicalTrials.gov registry record · NA
To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans
A NA study, sponsored by Charles Drew University of Medicine and Science.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT02802449 is a NA study that has completed, run by Charles Drew University of Medicine and Science. The registered enrollment target is 330 participants.
The verdict
NCT02802449, a NA study, has completed, sponsored by Charles Drew University of Medicine and Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
Three hundred thirty (330) overweight, pre-hypertensive/controlled hypertensive, African-American participants will be enrolled in a 8 week study to assess the effect of two administrations of Vitamin D3 on Vitamin D serum responsiveness as a function of clinical, biologic and genetic factors. The investigators anticipate that at least 300 participants will complete this study. Written, signed and dated informed consent to participate in the study will be given by the participant or a legally acceptable representative, in accordance with the International Conference on Harmonization (ICH) Good Clinical Practice (GCP) Guideline E6 and applicable regulations, before completing any study-related activities/procedures. The original signed and dated consent will be kept in the subject's research file and a copy given to the subject. A copy will also be placed in their medical record.
Interventions
- DRUG Placebo
- DRUG 25 Hydroxy- Vitamin D3 [25 (OH) D3]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2013-09 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02802449
The ClinicalTrials.gov registry entry for NCT02802449 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Charles Drew University of Medicine and Science, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02802449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02802449 about?
NCT02802449 is a clinical study titled "To Study the Nutri-Genomic Response of Vit-D Supplementation in African-Americans". Three hundred thirty (330) overweight, pre-hypertensive/controlled hypertensive, African-American participants will be enrolled in a 8 week study to assess the effect of two administrations of Vitamin D3 on Vitamin D serum responsiveness as a function of clinical, biologic and genetic factors. The i...
What is the current status of trial NCT02802449?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2013-09. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02802449?
The interventions under investigation include: Placebo (DRUG), 25 Hydroxy- Vitamin D3 [25 (OH) D3] (DRUG).
Who is sponsoring clinical trial NCT02802449?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.